Yasuo Kodera

497 total citations
14 papers, 405 citations indexed

About

Yasuo Kodera is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yasuo Kodera has authored 14 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yasuo Kodera's work include Cancer, Hypoxia, and Metabolism (2 papers), Metastasis and carcinoma case studies (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Yasuo Kodera is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Metastasis and carcinoma case studies (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Yasuo Kodera collaborates with scholars based in Japan and United States. Yasuo Kodera's co-authors include Fumiaki Koizumi, Yuka Kitamura, Yasufumi Katanasaka, Tomohide Tamura, Kazuto Nishio, Tatsuya Morimoto, Hitoshi Tsuda, Akihito Torii, Toshinori Hirai and T Kito and has published in prestigious journals such as Blood, International Journal of Cancer and Molecular Cancer.

In The Last Decade

Yasuo Kodera

14 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuo Kodera Japan 8 167 167 120 69 64 14 405
Qirong Geng China 12 172 1.0× 112 0.7× 158 1.3× 119 1.7× 117 1.8× 27 469
Ann W. Gramza United States 10 137 0.8× 200 1.2× 181 1.5× 72 1.0× 52 0.8× 22 552
Masayuki Itakura Japan 13 141 0.8× 246 1.5× 121 1.0× 118 1.7× 76 1.2× 47 474
T. Christopher Windham United States 7 203 1.2× 177 1.1× 110 0.9× 46 0.7× 35 0.5× 14 438
Keita Uchino Japan 12 86 0.5× 215 1.3× 151 1.3× 59 0.9× 39 0.6× 40 357
David Reynoso United States 8 135 0.8× 81 0.5× 155 1.3× 56 0.8× 48 0.8× 9 372
Daniele Lavacchi Italy 12 124 0.7× 303 1.8× 184 1.5× 75 1.1× 85 1.3× 46 476
Meiling Zhu China 14 199 1.2× 137 0.8× 156 1.3× 96 1.4× 92 1.4× 25 410
Keishi Nakamura Japan 14 130 0.8× 227 1.4× 168 1.4× 144 2.1× 85 1.3× 57 585
Xianghong Yang China 11 315 1.9× 96 0.6× 102 0.8× 71 1.0× 188 2.9× 21 520

Countries citing papers authored by Yasuo Kodera

Since Specialization
Citations

This map shows the geographic impact of Yasuo Kodera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Kodera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Kodera more than expected).

Fields of papers citing papers by Yasuo Kodera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Kodera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Kodera. The network helps show where Yasuo Kodera may publish in the future.

Co-authorship network of co-authors of Yasuo Kodera

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Kodera. A scholar is included among the top collaborators of Yasuo Kodera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Kodera. Yasuo Kodera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yamada, Suguru, Nakao Iwata, Mitsuro Kanda, et al.. (2017). Significance of lysil oxidase-like 2 (LOXL2) expression in hepatocellular carcinoma. HPB. 19. S88–S88. 1 indexed citations
2.
Togashi, Yosuke, Hiroki Sakamoto, Hidetoshi Hayashi, et al.. (2014). Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. Molecular Cancer. 13(1). 126–126. 27 indexed citations
3.
Katanasaka, Yasufumi, Yasuo Kodera, Mayu Yunokawa, et al.. (2014). Synergistic anti-tumor effects of a novel phosphatidyl inositol-3 kinase/mammalian target of rapamycin dual inhibitor BGT226 and gefitinib in non-small cell lung cancer cell lines. Cancer Letters. 347(2). 196–203. 26 indexed citations
4.
Katanasaka, Yasufumi, Yasuo Kodera, Yuka Kitamura, et al.. (2013). Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma. Molecular Cancer. 12(1). 31–31. 80 indexed citations
5.
Kodera, Yasuo, Yuka Kitamura, Senji Shirasawa, et al.. (2013). KRAS mutation confers resistance to antibody‐dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells. International Journal of Cancer. 134(9). 2146–2155. 38 indexed citations
6.
Kodera, Yasuo, Yasufumi Katanasaka, Yuka Kitamura, et al.. (2011). Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3. Breast Cancer Research. 13(3). R66–R66. 84 indexed citations
7.
Taguchi, Fumiko, Yasuo Kodera, Yasufumi Katanasaka, et al.. (2010). Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination. Investigational New Drugs. 29(6). 1198–1205. 16 indexed citations
8.
Fukui, Tomoya, Yasuo Kodera, Kazuto Nishio, et al.. (2009). Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells. Cancer Science. 100(6). 1137–1143. 1 indexed citations
9.
Suzuki, Ritsuro, Makoto Murata, Masahiro Kami, et al.. (2001). AML M0.の明確なサブタイプである骨髄/NK前駆細胞急性白血病. Blood. 98(11). 460. 2 indexed citations
10.
Nakanishi, Hayao, Yasuo Kodera, Yuko Yamamura, & M Tatematsu. (2001). [Rapid quantitative detection of free cancer cells in the peritoneal cavity of gastric cancer patients with real-time RT-PCR, and its prognostic significance].. PubMed. 28(6). 784–8. 4 indexed citations
11.
Kondo, Ken, Masazumi Fujiwara, Mai Murase, et al.. (1996). Severe Acute Metabolic Acidosis and Wernicke's Encephalopathy Following Chemotherapy with 5-Fluorouracil and Cisplatin: Case Report and Review of the Literature. Japanese Journal of Clinical Oncology. 26(4). 234–236. 32 indexed citations
12.
Kodera, Yasuo, et al.. (1996). The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer.. PubMed. 91(1). 49–53. 88 indexed citations
13.
Yazaki, Makoto, Y Morishima, Yasuo Kodera, et al.. (1994). [Coordination of unrelated bone marrow donors in the Tokai Bone Marrow Bank--psychological reactions of donors to donation].. PubMed. 35(8). 738–43. 1 indexed citations
14.
Murase, Mai, Kan Kondo, Yasuo Kodera, et al.. (1994). [The clinical effect of chemotherapy with 5-FU and low-dose CDDP in patients with advanced gastric cancer].. PubMed. 21(7). 1025–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026